These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31272272)
21. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087 [TBL] [Abstract][Full Text] [Related]
22. Kawasaki disease and the T-cell antigen receptor. Jason J; Montana E; Donald JF; Seidman M; Inge KL; Campbell R Hum Immunol; 1998 Jan; 59(1):29-38. PubMed ID: 9544237 [TBL] [Abstract][Full Text] [Related]
23. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children. Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677 [TBL] [Abstract][Full Text] [Related]
24. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease. Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967 [TBL] [Abstract][Full Text] [Related]
25. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study. Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897 [TBL] [Abstract][Full Text] [Related]
26. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease. Ehara H; Kiyohara K; Izumisawa Y; Ito T Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885 [TBL] [Abstract][Full Text] [Related]
27. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843 [TBL] [Abstract][Full Text] [Related]
28. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370 [TBL] [Abstract][Full Text] [Related]
29. Marker of T-cell activation is elevated in refractory Kawasaki disease. Suzuki H; Suenaga T; Takeuchi T; Shibuta S; Yoshikawa N Pediatr Int; 2010 Oct; 52(5):785-9. PubMed ID: 20487370 [TBL] [Abstract][Full Text] [Related]
30. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease. Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746 [TBL] [Abstract][Full Text] [Related]
31. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease. Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598 [TBL] [Abstract][Full Text] [Related]
32. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850 [TBL] [Abstract][Full Text] [Related]
33. Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia. Chen Y; Zhou Y; Chen P; Zhang P; Jia M; Tang Y Thromb Res; 2019 Aug; 180():1-9. PubMed ID: 31146120 [TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance. Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694 [TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease. Jang H; Kim KY; Kim DS Yonsei Med J; 2018 Jan; 59(1):113-118. PubMed ID: 29214785 [TBL] [Abstract][Full Text] [Related]
37. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742 [TBL] [Abstract][Full Text] [Related]
38. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705 [TBL] [Abstract][Full Text] [Related]
39. Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease. Choi IS; Lee MJ; Choi SA; Choi KS; Jeong IS; Cho HJ Front Pediatr; 2021; 9():792870. PubMed ID: 35186822 [TBL] [Abstract][Full Text] [Related]
40. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]